Exploration on the first-line treatment of ERBB2-altered advanced non-small cell lung cancer: A multicenter retrospective study.
Chen J, Xu C, Wang Q, Lv J, Lu W, Zhang Y, Yao Y, Gu X, Wu G, Hao Y, Pan W, Wang W, Zhang S, Lv T, Song Y, Wang D.
Chen J, et al. Among authors: lv j, lv t.
Lung Cancer. 2023 Sep;183:107315. doi: 10.1016/j.lungcan.2023.107315. Epub 2023 Jul 24.
Lung Cancer. 2023.
PMID: 37517117